NAYZILAM® (midazolam)* nasal spray, CIV

UCB

NAYZILAM is a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (i.e., seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern in patients with epilepsy 12 years of age and older.

Store at controlled room temperature 20°C to 25°C (68°F to 77°F). Excursions permitted to 15°C to 30°C (59°F to 86°F).

*NAYZILAM contains the benzodiazepine midazolam, a Schedule IV controlled substance under the Controlled Substances Act.